CTSS and autoimmune disease: These efforts underscore the expanding applications of CTSS inhibition, from autoimmune diseases (Sjögren’s syndrome) to oncology and vascular remodeling, yet highlight critical challenges in optimizing selectivity and minimizing off-target effects for future candidates.